Nuo Therapeutics, Inc.
|
164.2 Thousand USD
|
-485.1%
|
CNBX Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
Mosaic ImmunoEngineering Inc.
|
1.22 Million USD
|
21.785%
|
Evofem Biosciences, Inc.
|
8000.00 USD
|
-11909.538%
|
GB Sciences, Inc.
|
322 Thousand USD
|
-198.374%
|
Inhibitor Therapeutics, Inc.
|
- USD
|
-Infinity%
|
NanoSphere Health Sciences Inc.
|
- USD
|
-Infinity%
|
Skye Bioscience, Inc.
|
171.23 Thousand USD
|
-461.095%
|
Zenith Capital Corp.
|
4456.00 USD
|
-21461.109%
|
Agentix Corp.
|
- USD
|
-Infinity%
|
Arch Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Biomind Labs Inc.
|
- USD
|
-Infinity%
|
ContraFect Corporation
|
2.21 Million USD
|
56.527%
|
CSL Limited
|
11.23 Billion USD
|
99.991%
|
CytoDyn Inc.
|
141 Thousand USD
|
-581.392%
|
GlobeStar Therapeutics Corporation
|
- USD
|
-Infinity%
|
Neon Bloom, Inc.
|
- USD
|
-Infinity%
|
Northwest Biotherapeutics, Inc.
|
20.31 Million USD
|
95.27%
|
ProtoKinetix, Incorporated
|
- USD
|
-Infinity%
|
Propanc Biopharma, Inc.
|
58.64 Thousand USD
|
-1538.353%
|
Regen BioPharma, Inc.
|
149.61 Thousand USD
|
-542.161%
|
Santhera Pharmaceuticals Holding AG
|
1.75 Million USD
|
45.271%
|
SQZ Biotechnologies Company
|
20.9 Million USD
|
95.405%
|
Therapeutic Solutions International, Inc.
|
5512.00 USD
|
-17330.388%
|
Eiger BioPharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Intellipharmaceutics International Inc.
|
- USD
|
-Infinity%
|
Mesoblast Limited
|
100.29 Million USD
|
99.042%
|
Marizyme, Inc.
|
667.12 Thousand USD
|
-44.015%
|
Genus plc
|
228.2 Million USD
|
99.579%
|
Pharming Group N.V.
|
166.1 Million USD
|
99.422%
|
Nymox Pharmaceutical Corporation
|
- USD
|
-Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
1.4 Million USD
|
31.518%
|
IMV Inc.
|
27.39 Million USD
|
96.493%
|
AXIM Biotechnologies, Inc.
|
5.42 Million USD
|
82.295%
|
MultiCell Technologies, Inc.
|
36.43 USD
|
-2637185.205%
|
ONE Bio Corp.
|
592.19 Thousand USD
|
-62.237%
|
RVL Pharmaceuticals plc
|
55.61 Million USD
|
98.272%
|
Arno Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Emmaus Life Sciences, Inc.
|
2.22 Million USD
|
56.839%
|
Provectus Biopharmaceuticals, Inc.
|
25.29 Thousand USD
|
-3697.632%
|
Oncotelic Therapeutics, Inc.
|
1.89 Million USD
|
49.393%
|
THC Farmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Acro Biomedical Co., Ltd.
|
- USD
|
-Infinity%
|
Alpha Cognition Inc.
|
- USD
|
-Infinity%
|
Enzolytics Inc.
|
- USD
|
-Infinity%
|
MetaStat, Inc.
|
- USD
|
-Infinity%
|
argenx SE
|
15.35 Million USD
|
93.743%
|
Enzon Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Endonovo Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Genscript Biotech Corporation
|
287.12 Million USD
|
99.665%
|
Nanobac Pharmaceuticals, Incorporated
|
- USD
|
-Infinity%
|
Institute of Biomedical Research Corp.
|
- USD
|
-Infinity%
|
Sigyn Therapeutics, Inc.
|
126.3 Thousand USD
|
-660.687%
|
WPD Pharmaceuticals Inc.
|
229.29 Thousand USD
|
-319.015%
|
Cotinga Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
VioQuest Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
PsyBio Therapeutics Corp.
|
- USD
|
-Infinity%
|
Adynxx, Inc.
|
- USD
|
-Infinity%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Accustem Sciences Inc.
|
- USD
|
-Infinity%
|
Helix BioMedix, Inc.
|
- USD
|
-Infinity%
|
EV Biologics, Inc.
|
- USD
|
-Infinity%
|
Q BioMed Inc.
|
- USD
|
-Infinity%
|
Capstone Therapeutics Corp.
|
8.26 Million USD
|
88.374%
|
American Oriental Bioengineering, Inc.
|
554.59 Thousand USD
|
-73.238%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
-Infinity%
|
BioStem Technologies, Inc.
|
265.63 Thousand USD
|
-261.685%
|
Curative Biotechnology, Inc.
|
- USD
|
-Infinity%
|
HST Global, Inc.
|
- USD
|
-Infinity%
|
Burzynski Research Institute, Inc.
|
- USD
|
-Infinity%
|
Wesana Health Holdings Inc.
|
- USD
|
-Infinity%
|
Halberd Corporation
|
150 Thousand USD
|
-540.509%
|
Resverlogix Corp.
|
- USD
|
-Infinity%
|
Cell Source, Inc.
|
- USD
|
-Infinity%
|
RespireRx Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
GeneThera, Inc.
|
- USD
|
-Infinity%
|
AVAX Technologies, Inc.
|
- USD
|
-Infinity%
|
Ember Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
NovAccess Global Inc.
|
- USD
|
-Infinity%
|
Kadimastem Ltd
|
229.69 Thousand USD
|
-318.285%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
-Infinity%
|
Rasna Therapeutics, Inc.
|
- USD
|
-Infinity%
|
Oncology Pharma Inc.
|
- USD
|
-Infinity%
|
Reve Technologies, Inc.
|
1064.00 USD
|
-90197.274%
|
LadRx Corporation
|
- USD
|
-Infinity%
|
Regen BioPharma, Inc.
|
149.61 Thousand USD
|
-542.161%
|
Affymax, Inc.
|
- USD
|
-Infinity%
|
Itoco Inc.
|
- USD
|
-Infinity%
|
Pathfinder Cell Therapy, Inc.
|
- USD
|
-Infinity%
|
Mobile Lads Corp.
|
- USD
|
-Infinity%
|
International Stem Cell Corporation
|
445 Thousand USD
|
-115.902%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Bioxytran, Inc.
|
- USD
|
-Infinity%
|
NDT Pharmaceuticals Inc.
|
- USD
|
-Infinity%
|
Qrons Inc.
|
80 Thousand USD
|
-1100.954%
|
Alseres Pharmaceuticals, Inc.
|
7.81 Million USD
|
87.714%
|
SYBLEU INC
|
300 Thousand USD
|
-220.254%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
-Infinity%
|
Nascent Biotech, Inc.
|
- USD
|
-Infinity%
|
Rebus Holdings, Inc.
|
- USD
|
-Infinity%
|
ImmunoCellular Therapeutics, Ltd.
|
369.04 Thousand USD
|
-160.335%
|
GlobeImmune, Inc.
|
- USD
|
-Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
-Infinity%
|
ProText Mobility, Inc.
|
- USD
|
-Infinity%
|
Cardax, Inc.
|
- USD
|
-Infinity%
|
VG Life Sciences Inc.
|
- USD
|
-Infinity%
|
Kaleido Biosciences, Inc.
|
- USD
|
-Infinity%
|
Advaxis, Inc.
|
8.15 Million USD
|
88.211%
|
Adhera Therapeutics, Inc.
|
- USD
|
-Infinity%
|
RenovaCare, Inc.
|
- USD
|
-Infinity%
|
Regnum Corp.
|
- USD
|
-Infinity%
|
Innovation Pharmaceuticals Inc.
|
457 Thousand USD
|
-110.233%
|
Neutra Corp.
|
- USD
|
-Infinity%
|
Windtree Therapeutics, Inc.
|
1.16 Million USD
|
17.247%
|
PureTech Health plc
|
18.25 Million USD
|
94.736%
|
Coeptis Therapeutics, Inc.
|
150 Thousand USD
|
-540.509%
|
IXICO plc
|
275 Thousand USD
|
-249.368%
|
IntelGenx Technologies Corp.
|
11.83 Million USD
|
91.885%
|
Gelesis Holdings, Inc.
|
26.3 Million USD
|
96.348%
|
CSL Limited
|
11.23 Billion USD
|
99.991%
|
Cellectis S.A.
|
36.21 Million USD
|
97.347%
|